OPTOFLUIDICS, INC.

BURLINGAME, CA · Medtech · Acquired

Particle identification instrument and algorithm for detecting and classifying contaminant particles in biopharmaceutical formulations

Claim this profile

Follows are private to you and power your alerts

Updated · opfluid.com

Sector
Medtech
Headquarters
BURLINGAME, CA
Latest Form D
$6M, Jul 2022
Total capital
$21.5M
Federal grants
$3.1M
5 awards · 2015–2018
Rank in peer group#329 of 538
Private capital raised
$18.4M
3 Form D · last Jul 2022
52 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
9
10 pending · first 2021
Rank in peer group#67 of 538

Capital timeline

20152016201720182019202020212022FEDERAL ↑EQUITY ↓Cumulative $21.5M$486K$150K$1.5M$750K$204K1st Form D$5.6M2nd Form D$6.7M
2015201720192021FEDERAL ↑EQUITY ↓Cumulative $21.5M$486K$1.5M$750K$204K1st Form D$5.6M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$6M
  • Private capital raisedForm D · SEC · 2nd filing$6.7M
  • Private capital raisedForm D · SEC · 1st filing$5.6M
  • Federal grantHealth and Human S · Phase I · Partelligence$204K
  • Federal grantHealth and Human S · Phase II · FlowID: An Advanced Particle Imaging and Identification System to Improve the Health and Safety of Protein Therapeutics$750K
  • Federal grantHealth and Human S · Phase II · FlowID An Advanced Particle Imaging and Identification System to Improve the Health and Safety of Protein Therapeutics$1.5M
  • Federal grantHealth and Human S · Phase I · Excelsior: A High Throughput Particle Spectroscopic Characterization System for Biologic QA/QC$150K
Show 1 earlier federal award
  • Federal grantHealth and Human S · Phase II · BioPrism - An Optical Chromatograph$486K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

40months

from OPTOFLUIDICS, INC.’s first federal award to its first private round.

First federal award · Aug 2015
Health and Human S · $486K
First Form D · Dec 2018
$5.6M · 1st Form D
Awards before first raise
5 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#67 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Bernardo CordovezResearcherExecutive OfficerLinked by 3 patents
  • Robert HartResearcherExecutive OfficerLinked by $204K in grants as PI
  • Casey McGlynnExecutive OfficerNamed in SEC Form D filings
  • Chad SouvignierDirectorNamed in SEC Form D filings
  • Joseph KeeganDirectorNamed in SEC Form D filings
  • Rick GordonExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
  • Robert WickeExecutive Officer, DirectorNamed in SEC Form D filings
  • Shahram HejaziDirectorNamed in SEC Form D filings
  • William SniderDirectorNamed in SEC Form D filings

What it has protected

USPTO · 9 granted of 19
Show all 19 patent records
  • OxyDial IncSimilar federal contract value in Medtech · null in contracts
  • GRIP Molecular Technologies Inc.Similar federal contract value in Medtech · null in contracts
  • Sonomotion Inc.Similar federal contract value in Medtech · null in contracts
  • MERU BIOTECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
  • B2M MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
  • BIOMOTUM, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .